Pith. sign in

REVIEW 3 major objections 4 minor 33 references

A binary silver label — a medication mention or lab threshold — can be fed directly into PheNorm's denoising step to produce a continuous EHR phenotype score that ranks patients more accurately than the raw binary rule.

Reviewed by Pith at T0; open to challenge. T0 means a machine referee read the full paper against a public rubric. the ladder, T0–T4 →

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

T0 review · deepseek-v4-flash

2026-08-01 15:26 UTC pith:U53HJKYG

load-bearing objection Binary PheNorm is a useful, clearly written extension of PheNorm to binary silver labels, but the 'denoising' claim overreaches: the real-data gains partly reflect covariate augmentation, and the ranking property lacks theoretical support and is fragile under different working models. the 3 major comments →

arxiv 2607.18431 v1 pith:U53HJKYG submitted 2026-07-20 stat.ME cs.LGstat.ML

Using binary silver labels in electronic health records-based computable phenotyping algorithms

Shuhe Wang , Matthew T. Slaughter , Jennifer C. Nelson , Brian D. Williamson This is my paper
classification stat.ME cs.LGstat.ML
keywords binary silver labelsPheNormweakly supervised phenotypingelectronic health recordsdenoising regressionlasso regularizationphenotype scoreAUC
verification ladder T0 review T1 audit T2 compute T3 formal T4 reserved

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper extends PheNorm, a weakly supervised phenotyping method, to settings where the only silver label is a binary indicator such as a medication-administration flag or a laboratory-threshold exceedance. It claims that using the binary label as the target of the corruption-and-regression denoising step, with linear regression and no EM calibration, yields a continuous score with substantially better discrimination than the raw binary rule: in anaphylaxis, AUC rises from 0.793 to about 0.89; in acute pancreatitis, from 0.736 to about 0.81. The same machinery can combine binary and count labels, and a lasso-regularized version handles sparse high-dimensional EHR feature sets. This matters because binary indicators are common and cheap to extract, and gold-standard labels are often scarce.

Core claim

The central claim is that binary silver labels need no special transformation: they can be used directly as dependent variables in the PheNorm denoising regression. For each binary silver label j, the algorithm corrupts the feature matrix by replacing random entries with column means, fits an ordinary least-squares regression of the binary label on the corrupted features, and evaluates the fitted regression at the uncorrupted features to obtain a per-subject score. This score is a continuous ranking, not a calibrated probability, and the paper argues that calibration is unnecessary for many phenotyping tasks. In the two real-world applications, the denoised score improved AUC over the raw bi

What carries the argument

The corruption-and-regression denoising step: the feature matrix is corrupted by replacing randomly selected entries with their column means, a linear regression of the silver label(s) on the corrupted matrix is fitted, and the fitted model is evaluated on the uncorrupted matrix to obtain a denoised score. This mechanism transfers information from the auxiliary EHR/NLP covariates to the noisy surrogate, producing a smoother ranking.

Load-bearing premise

The load-bearing premise is that the linear regression of the binary silver label on the corrupted feature matrix produces a score that orders individuals by true phenotype risk, even though the target is a noisy surrogate and the model is linear; the paper supports this empirically rather than with a formal identifiability argument.

What would settle it

If, in a new EHR dataset with a known informative binary silver label and rich auxiliary covariates, Binary PheNorm's score produced a lower AUC than the raw binary rule (or equal to it), that would contradict the paper's core claim. More specifically, a simulation in which the binary label is generated as a non-monotone function of the true phenotype (e.g., label = 1 when phenotype is in the middle range) should cause the linear denoising score to rank patients incorrectly, indicating the monotonicity assumption is essential.

Watch this falsifier — get emailed when new claim-graph text bears on it.

If this is right

  • Binary medication, laboratory-threshold, or NLP-mention indicators can serve as primary silver labels in PheNorm without the log-transform, utilization normalization, or mixture-model calibration required by the original count-based method.
  • Combining binary and count silver labels in one denoising framework can improve discrimination beyond either alone, as seen in acute pancreatitis where the combined model reached AUC 0.89.
  • Lasso-regularized denoising stabilizes the score in high-dimensional, sparse EHR feature sets and also resolves non-convergence problems seen with ordinary least squares.
  • Because gold-standard labels are used only for evaluation, the full cohort can be used to fit the final score, and train/test or cross-validation strategies give similar performance estimates.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • If the denoised score's ranking quality derives from the assumption that the binary label is a monotone noisy function of true phenotype, then the method should struggle with binary surrogates that are non-monotone or conditionally independent of phenotype; a natural test would be to apply Binary PheNorm to a deliberately non-informative binary rule and check that no improvement occurs.
  • The same corruption-and-regression trick could be applied to other types of weak supervision, such as noisy ordinal or multi-category labels, as long as the regression target is on a scale where linear regression behaves sensibly.
  • The paper's two empirical successes share an important feature: the binary label is a clinically specific treatment (epinephrine) or a standardized diagnostic threshold (lipase >3× ULN). A broader replication across phenotypes with less specific binary indicators would clarify how much of the gain comes from the denoising step versus the informativeness of the chosen rule.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit.

Referee Report

3 major / 4 minor

Summary. The paper proposes Binary PheNorm, an extension of the PheNorm weakly supervised phenotyping framework designed for binary silver labels. Instead of log-transforming and fitting a mixture model as in Original PheNorm, Binary PheNorm uses the binary silver label directly as the target in a corruption-and-regression denoising step, followed by averaging of label-specific scores; a lasso-regularized version is also introduced. The method is evaluated in extensive simulations (2500 replications per main scenario) and in two EHR applications, anaphylaxis and acute pancreatitis, where it is reported to increase AUC from 0.793 to 0.891–0.892 and from 0.736 to 0.805–0.819, respectively, relative to using the raw binary silver label alone. The authors also discuss combined models that use both binary and count labels and integration with sureLDA, and they provide public code for the simulations.

Significance. If the method performs as claimed, it fills a practical gap: PheNorm and related methods were designed for count-valued surrogates, while binary indicators (medication administration, lab thresholds, NLP mentions) are common in EHR phenotyping. The paper's strengths include a transparent weakly supervised framework (gold labels used only for evaluation), a large simulation study, consistent results across no-split, train/test, and CV evaluation strategies, and publicly available code for simulations. The paper also honestly states limitations, including that the output is not calibrated and that only two real-data applications are presented. However, the central claim that the denoising step improves ranking over the raw binary rule is not yet fully supported, because the simulations assume favorable independent label noise and the real-data comparisons conflate denoising with covariate augmentation.

major comments (3)
  1. [Section 2.3, 3.3, and Table S1] The ranking property of the Binary PheNorm score is only established empirically under simulations in which binary silver labels are independent flips of the true phenotype, P(b=y)=0.8. In that model, E[B|X] is a monotone function of P(Y=1|X), so the OLS denoising regression is favorably identified. EHR binary labels such as epinephrine mention or lipase>3×ULN are unlikely to be independent flips of the phenotype; label error may depend on severity, documentation, and utilization. Section 2.3 provides no argument that the corruption-and-regression score preserves true phenotype ranking under covariate-dependent misclassification. Table S1 shows that logistic-regression denoising collapses under the same favorable simulation (AUC 0.658 vs 0.906 linear), indicating that the ranking property is not a stable consequence of the procedure itself. The authors should provide a formal condition u
  2. [Section 4.3–4.4, Tables 4–5] The headline comparisons 'Binary PheNorm vs. raw binary rule' are not apples-to-apples: the raw rule uses only the binary silver label, while Binary PheNorm uses the binary label plus the full auxiliary covariate set. The reported AUC gain could therefore be driven by covariate augmentation rather than by the corruption-and-regression denoising step. A no-corruption baseline is needed—for example, an ordinary (or lasso) linear regression of the binary label on the binary label plus covariates, evaluated with the same sampling weights and threshold—to isolate the effect of the random corruption step. Without such a baseline, the specific claim that 'the PheNorm denoising step can improve over the raw binary rule' is not established.
  3. [Tables 4–5] Real-data AUCs are reported without confidence intervals or uncertainty estimates, despite the chart-reviewed samples being small (anaphylaxis: 58 positives among 145; acute pancreatitis: 179 among 386). The improvements are large, but no evidence is given that they exceed sampling variation. For example, the train/test and CV results for Binary PheNorm in anaphylaxis are 0.891 and 0.891, while the raw rule is 0.793; this is likely real, but the paper should report CIs or bootstrap intervals, especially because threshold-based metrics are weighted from stratified sampling. This is a load-bearing gap for the real-data conclusions.
minor comments (4)
  1. [Section 1] The text says 'Food and Drug Association' (FDA); the correct name is 'Food and Drug Administration'.
  2. [Section 2.2 and 3.3] The count-label generation in Section 3.3 (c = log(exp(e)*n^{1/2}) = e + 0.5 log n) is not clearly connected to the utilization normalization formula in Section 2.2 (ecij = log(1+c_ij) - alpha_j log(1+n_i)). Clarify whether the simulation uses the same normalization and how alpha_j is chosen.
  3. [Section 3.4] The simulation description for the sparse high-dimensional setting says 'two binary silver labels and two count silver labels' are generated, but the fitted models use 'one binary silver label and one count silver label.' This is understandable but could be stated more explicitly to avoid confusion.
  4. [Section 5] The Discussion says that in acute pancreatitis the Binary PheNorm AUC improved to '0.819 in both cross-validation and no-split analyses,' but Table 5 shows CV AUC 0.809 and no-split 0.819. Please correct this internal inconsistency.

Circularity Check

0 steps flagged

No significant circularity: the denoised score is fit from silver labels and covariates only, with gold labels reserved for evaluation; the sole same-author citation is data provenance, not a load-bearing inference.

full rationale

The derivation chain in Sections 2.3–2.7 is not circular. Binary PheNorm’s score is t_ij = β̂_0j + x_i^T β̂_j, obtained by regressing the binary silver label b_ij on a corrupted matrix X that contains b and auxiliary covariates; the gold-standard phenotype y_i is explicitly excluded from model fitting (“gold-standard labels are not used for estimating the score,” Section 2.7). The reported AUCs are therefore external evaluations against chart review, not reproductions of a fitted target. The improvement over the raw binary rule is an empirical result of the regression borrowing information from covariates; no equation defines the true phenotype in terms of the score, so the “prediction” is not equivalent to the input by construction. The only same-author citation, Williamson et al. (2026), supplies the anaphylaxis dataset (Section 4.1) and is data provenance rather than a load-bearing analytical premise; the identifiability argument relies on external literature (Gyllenberg et al. 1994), and the original PheNorm framework is cited externally (Yu et al. 2018). The fragility shown in Supplementary Table S1—logistic denoising AUC 0.658 vs linear 0.906—and the absence of a no-corruption baseline are external-validity concerns about the ranking property under differential label noise, not circularity: they suggest the empirical support is narrower than the general claim, but they do not make the reported results equal to the fitting inputs. The paper’s own limitation statement (“Further evaluation in additional outcomes and health systems is needed”) is weighed here as a scope limitation, not as evidence of circular derivation.

Axiom & Free-Parameter Ledger

2 free parameters · 5 axioms · 0 invented entities

The method rests on a small set of untested modeling assumptions: the corruption-and-regression procedure yields a valid ranking, the binary label is informative, the auxiliary covariates add signal, and evaluation without data splitting is unbiased. The only hand-set numeric parameter is the corruption rate (0.4 in the supplement); the lasso penalty is data-driven.

free parameters (2)
  • corruption rate = 0.4
    Supplementary Section S1 states 'the same corruption rate of 0.4'. The fraction of feature entries replaced by column means in the denoising step is chosen by the authors and affects the score.
  • score combination rule = simple average
    Section 2.3: label-specific scores are averaged (t_i = k_b^{-1} sum_j t_ij). This prespecified rule avoids gold-label weights but is a modeling choice.
axioms (5)
  • domain assumption Random corruption of features by replacement with column means yields a denoising target that, when regressed, produces a score valid for phenotype ranking.
    Core mechanism of Binary PheNorm (Section 2.3); no formal justification provided; supported empirically by simulations and applications.
  • domain assumption The binary silver label is an informative surrogate for the true phenotype (e.g., P(b=y|y) > 1/2 in simulations; clinical rationale for epinephrine/lipase indicators).
    Necessary for the method to improve over chance; acknowledged in Discussion as a limitation when labels are uninformative (anaphylaxis epinephrine administration label, raw AUC 0.601).
  • standard math Finite mixtures of multivariate Bernoulli distributions are not identifiable (Gyllenberg et al., 1994).
    Invoked in Section 2.3 to justify avoiding EM calibration for binary labels.
  • domain assumption Auxiliary EHR and NLP covariates contain phenotype information beyond the silver label.
    The denoising regression borrows from covariates; if covariates were pure noise, the score would reduce to a smoothed silver label without extra discrimination.
  • domain assumption Evaluation on the chart-reviewed sample without data splitting is valid because gold labels are not used in model fitting.
    Section 2.7 argues and simulation (Table 1) supports that no-split, split, and CV give similar results; this underpins the no-split real-data results.

pith-pipeline@v1.3.0-alltime-deepseek · 17078 in / 17096 out tokens · 150219 ms · 2026-08-01T15:26:46.044061+00:00 · methodology

0 comments
read the original abstract

Gold-standard phenotype labels are often unavailable at scale in electronic health record (EHR) studies because they require manual chart review. Weakly supervised phenotyping methods instead use silver-standard labels, such as diagnosis-code counts, natural language processing (NLP) mentions, medication indicators, or laboratory thresholds. PheNorm is widely used for this purpose, but its original formulation was designed for count-valued silver labels and relies on log transformation, utilization normalization, and Gaussian mixture modeling. These steps are not directly suited to binary silver labels, which are common and may be highly informative. We propose Binary PheNorm, an extension that uses binary silver labels directly in the corruption-and-regression denoising step and produces a continuous phenotype score without EM calibration. We also consider a lasso-regularized version for high-dimensional EHR settings and combined models using both binary and count labels. In simulations, Binary PheNorm achieved strong discrimination using binary labels alone and often improved performance when combined with count labels. In anaphylaxis, AUC increased from 0.793 for an epinephrine-mention indicator to 0.891-0.892 after Binary PheNorm. In acute pancreatitis, AUC increased from 0.736 for a lipase-threshold indicator to 0.805-0.819. These results support Binary PheNorm as a practical weakly supervised approach when informative binary silver labels are available.

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

33 extracted references

  1. [1]

    2026 , doi =

    Bann, Maralyssa A and Carrell, David S and Gruber, Susan and others , title =. 2026 , doi =

    2026

  2. [2]

    medRxiv , year=

    Identifying anaphylaxis using weakly-supervised prediction models and natural language processing , author=. medRxiv , year=

  3. [3]

    Statistics in Medicine , volume=

    Using Simulation Studies to Evaluate Statistical Methods , author=. Statistics in Medicine , volume=. 2019 , publisher=

    2019

  4. [4]

    Enabling Phenotypic Big Data with

    Yu, Sheng and Ma, Yumeng and Gronsbell, Jessica and others , journal=. Enabling Phenotypic Big Data with. 2018 , publisher=

    2018

  5. [5]

    American Journal of Epidemiology , volume=

    Improving Methods of Identifying Anaphylaxis for Medical Product Safety Surveillance Using Natural Language Processing and Machine Learning , author=. American Journal of Epidemiology , volume=. 2023 , publisher=

    2023

  6. [6]

    Platt, Richard and Brown, Jeffrey S and Robb, Melissa and others , journal=. The

  7. [7]

    Platt, Richard and Carnahan, Ryan M and Brown, Jeffrey S and others , journal=. The. 2012 , publisher=

    2012

  8. [8]

    Clinical Reviews in Allergy & Immunology , volume=

    The Epidemiology of Anaphylaxis , author=. Clinical Reviews in Allergy & Immunology , volume=. 2018 , publisher=

    2018

  9. [9]

    Second Symposium on the Definition and Management of Anaphylaxis: Summary Report---Second

    Sampson, Hugh A and Mu. Second Symposium on the Definition and Management of Anaphylaxis: Summary Report---Second. Journal of Allergy and Clinical Immunology , volume=. 2006 , publisher=

    2006

  10. [10]

    Epidemiology of Anaphylaxis: Findings of the

    Lieberman, Phil and Camargo Jr, Carlos A and Bohlke, Kari and others , journal=. Epidemiology of Anaphylaxis: Findings of the. 2006 , publisher=

    2006

  11. [11]

    Validation of Anaphylaxis in the

    Walsh, Kathleen E and Cutrona, Sarah L and Foy, Sarah and others , journal=. Validation of Anaphylaxis in the. 2013 , publisher=

    2013

  12. [12]

    2020 , publisher=

    Ahuja, Yuri and Zhou, Doudou and He, Zeling and others , journal=. 2020 , publisher=

    2020

  13. [13]

    High-Throughput Multimodal Automated Phenotyping (

    Liao, Katherine P and Sun, Jiehuan and Cai, Tianrun A and others , journal=. High-Throughput Multimodal Automated Phenotyping (. 2019 , publisher=

    2019

  14. [14]

    Journal of the Royal Statistical Society: Series B (Methodological) , volume=

    Regression Shrinkage and Selection via the Lasso , author=. Journal of the Royal Statistical Society: Series B (Methodological) , volume=. 1996 , publisher=

    1996

  15. [15]

    Maximum Likelihood from Incomplete Data via the

    Dempster, Arthur P and Laird, Nan M and Rubin, Donald B , journal=. Maximum Likelihood from Incomplete Data via the. 1977 , publisher=

    1977

  16. [16]

    The Meaning and Use of the Area Under a Receiver Operating Characteristic (

    Hanley, James A and McNeil, Barbara J , journal=. The Meaning and Use of the Area Under a Receiver Operating Characteristic (

  17. [17]

    Statistics in Medicine , volume=

    A Solution to the Problem of Separation in Logistic Regression , author=. Statistics in Medicine , volume=. 2002 , publisher=

    2002

  18. [18]

    Journal of Statistical Software , volume=

    Regularization Paths for Generalized Linear Models via Coordinate Descent , author=. Journal of Statistical Software , volume=

  19. [19]

    Annals of Allergy, Asthma & Immunology , volume=

    Anaphylaxis: A 2023 Practice Parameter Update , author=. Annals of Allergy, Asthma & Immunology , volume=. 2024 , publisher=

    2023

  20. [20]

    2020 , publisher=

    Cardona, Victoria and Ansotegui, Ignacio J and Ebisawa, Motohiro and others , journal=. 2020 , publisher=

    2020

  21. [21]

    Classification of Acute Pancreatitis---2012: Revision of the

    Banks, Peter A and Bollen, Thomas L and Dervenis, Christos and others , journal=. Classification of Acute Pancreatitis---2012: Revision of the. 2013 , publisher=

    2012

  22. [22]

    Journal of Applied Probability , volume=

    Non-Uniqueness in Probabilistic Numerical Identification of Bacteria , author=. Journal of Applied Probability , volume=. 1994 , publisher=

    1994

  23. [23]

    Biometrical Journal , volume=

    Clinical Risk Prediction Models and Informative Cluster Size: Assessing the Performance of a Suicide Risk Prediction Algorithm , author=. Biometrical Journal , volume=. 2021 , publisher=

    2021

  24. [24]

    The Unified Medical Language System (

    Bodenreider, Olivier , journal=. The Unified Medical Language System (. 2004 , publisher=

    2004

  25. [25]

    and Wood, Louise and Wood, Sue , journal=

    Brown, Elliot G. and Wood, Louise and Wood, Sue , journal=. The Medical Dictionary for Regulatory Activities (. 1999 , doi=

    1999

  26. [26]

    Baggs, James and Gee, Julianne and Lewis, Edwin and others , journal=. The. 2011 , publisher=

    2011

  27. [27]

    1997 , publisher=

    Chen, Robert T and Glasser, John W and Rhodes, Philip H and others , journal=. 1997 , publisher=

    1997

  28. [28]

    McNeil, Michael M and Gee, Julianne and Weintraub, Eric S and others , journal=. The. 2014 , publisher=

    2014

  29. [29]

    Proceedings of the 34th International Conference on Machine Learning , pages=

    Learning the Structure of Generative Models Without Labeled Data , author=. Proceedings of the 34th International Conference on Machine Learning , pages=. 2017 , organization=

    2017

  30. [30]

    Epidemiology , volume=

    Validation of Acute Pancreatitis among Adults in an Integrated Healthcare System , author=. Epidemiology , volume=. 2023 , publisher=

    2023

  31. [31]

    2009 , publisher=

    The Elements of Statistical Learning: Data Mining, Inference, and Prediction , author=. 2009 , publisher=

    2009

  32. [32]

    Statistics Surveys , volume=

    A Survey of Cross-Validation Procedures for Model Selection , author=. Statistics Surveys , volume=

  33. [33]

    Nature Communications , year=

    InfEHR: Clinical phenotype resolution through deep geometric learning , author=. Nature Communications , year=